vs

Side-by-side financial comparison of BCB BANCORP INC (BCBP) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $26.2M, roughly 1.6× BCB BANCORP INC). Neuronetics, Inc. runs the higher net margin — -17.2% vs -49.7%, a 32.4% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 13.1%). BCB BANCORP INC produced more free cash flow last quarter ($34.9M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 1.8%).

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

BCBP vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.6× larger
STIM
$41.8M
$26.2M
BCBP
Growing faster (revenue YoY)
STIM
STIM
+72.6% gap
STIM
85.7%
13.1%
BCBP
Higher net margin
STIM
STIM
32.4% more per $
STIM
-17.2%
-49.7%
BCBP
More free cash flow
BCBP
BCBP
$34.2M more FCF
BCBP
$34.9M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
1.8%
BCBP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCBP
BCBP
STIM
STIM
Revenue
$26.2M
$41.8M
Net Profit
$-12.0M
$-7.2M
Gross Margin
52.0%
Operating Margin
-71.9%
-12.1%
Net Margin
-49.7%
-17.2%
Revenue YoY
13.1%
85.7%
Net Profit YoY
-467.6%
43.2%
EPS (diluted)
$-0.73
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCBP
BCBP
STIM
STIM
Q4 25
$26.2M
$41.8M
Q3 25
$26.5M
$37.3M
Q2 25
$25.2M
$38.1M
Q1 25
$23.8M
$32.0M
Q4 24
$23.1M
$22.5M
Q3 24
$26.2M
$18.5M
Q2 24
$20.4M
$16.4M
Q1 24
$25.3M
$17.4M
Net Profit
BCBP
BCBP
STIM
STIM
Q4 25
$-12.0M
$-7.2M
Q3 25
$4.3M
$-9.0M
Q2 25
$3.6M
$-10.1M
Q1 25
$-8.3M
$-12.7M
Q4 24
$3.3M
$-12.7M
Q3 24
$6.7M
$-13.3M
Q2 24
$2.8M
$-9.8M
Q1 24
$5.9M
$-7.9M
Gross Margin
BCBP
BCBP
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
BCBP
BCBP
STIM
STIM
Q4 25
-71.9%
-12.1%
Q3 25
21.9%
-19.6%
Q2 25
19.9%
-21.1%
Q1 25
-49.2%
-34.4%
Q4 24
19.9%
-51.0%
Q3 24
35.7%
-41.7%
Q2 24
19.5%
-51.7%
Q1 24
33.0%
-39.4%
Net Margin
BCBP
BCBP
STIM
STIM
Q4 25
-49.7%
-17.2%
Q3 25
16.1%
-24.3%
Q2 25
14.2%
-26.6%
Q1 25
-35.0%
-39.6%
Q4 24
14.1%
-56.4%
Q3 24
25.5%
-72.0%
Q2 24
13.8%
-59.8%
Q1 24
23.2%
-45.2%
EPS (diluted)
BCBP
BCBP
STIM
STIM
Q4 25
$-0.73
$-0.10
Q3 25
$0.22
$-0.13
Q2 25
$0.18
$-0.15
Q1 25
$-0.51
$-0.21
Q4 24
$0.17
$-0.34
Q3 24
$0.36
$-0.44
Q2 24
$0.14
$-0.33
Q1 24
$0.32
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCBP
BCBP
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$304.3M
$22.4M
Total Assets
$3.3B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCBP
BCBP
STIM
STIM
Q4 25
$28.1M
Q3 25
$28.0M
Q2 25
$11.0M
Q1 25
$20.2M
Q4 24
$18.5M
Q3 24
$20.9M
Q2 24
$42.6M
Q1 24
$47.7M
Total Debt
BCBP
BCBP
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
BCBP
BCBP
STIM
STIM
Q4 25
$304.3M
$22.4M
Q3 25
$318.5M
$27.4M
Q2 25
$315.7M
$27.1M
Q1 25
$314.7M
$35.5M
Q4 24
$323.9M
$27.7M
Q3 24
$328.1M
$9.4M
Q2 24
$320.7M
$19.4M
Q1 24
$320.1M
$27.7M
Total Assets
BCBP
BCBP
STIM
STIM
Q4 25
$3.3B
$141.6M
Q3 25
$3.4B
$145.5M
Q2 25
$3.4B
$134.7M
Q1 25
$3.5B
$142.0M
Q4 24
$3.6B
$140.9M
Q3 24
$3.6B
Q2 24
$3.8B
$96.8M
Q1 24
$3.8B
$103.8M
Debt / Equity
BCBP
BCBP
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCBP
BCBP
STIM
STIM
Operating Cash FlowLast quarter
$35.9M
$908.0K
Free Cash FlowOCF − Capex
$34.9M
$692.0K
FCF MarginFCF / Revenue
133.3%
1.7%
Capex IntensityCapex / Revenue
4.0%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$58.2M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCBP
BCBP
STIM
STIM
Q4 25
$35.9M
$908.0K
Q3 25
$8.7M
$-785.0K
Q2 25
$10.3M
$-3.5M
Q1 25
$5.0M
$-17.0M
Q4 24
$67.7M
$-8.6M
Q3 24
$43.5M
$-5.4M
Q2 24
$8.1M
$-5.0M
Q1 24
$8.3M
$-12.0M
Free Cash Flow
BCBP
BCBP
STIM
STIM
Q4 25
$34.9M
$692.0K
Q3 25
$8.5M
$-899.0K
Q2 25
$10.2M
$-3.8M
Q1 25
$4.7M
$-17.2M
Q4 24
$66.5M
$-8.7M
Q3 24
$43.4M
$-5.8M
Q2 24
$8.1M
$-5.6M
Q1 24
$8.1M
$-12.4M
FCF Margin
BCBP
BCBP
STIM
STIM
Q4 25
133.3%
1.7%
Q3 25
32.0%
-2.4%
Q2 25
40.4%
-9.9%
Q1 25
19.8%
-53.8%
Q4 24
287.5%
-38.6%
Q3 24
166.0%
-31.3%
Q2 24
39.6%
-34.0%
Q1 24
32.3%
-71.1%
Capex Intensity
BCBP
BCBP
STIM
STIM
Q4 25
4.0%
0.5%
Q3 25
1.1%
0.3%
Q2 25
0.6%
0.7%
Q1 25
1.2%
0.7%
Q4 24
5.3%
0.4%
Q3 24
0.3%
2.1%
Q2 24
0.2%
3.7%
Q1 24
0.6%
2.2%
Cash Conversion
BCBP
BCBP
STIM
STIM
Q4 25
Q3 25
2.05×
Q2 25
2.90×
Q1 25
Q4 24
20.70×
Q3 24
6.53×
Q2 24
2.88×
Q1 24
1.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons